PRESS RELEASE AND MEDIA

PRESS CONTACTS
KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Hong Kong
Strategic Collaboration to Deliver End-to-End Healthcare Supply Chain Solutions

2025-11-05 Hong Kong

KLN Logistics Group Limited (‘KLN’; Stock Code 0636.HK) is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma (Hong Kong) Limited (‘KLN Pharma’), as the fourth-party logistics (4PL) service provider for Australian skincare brand Ego Pharmaceuticals in Hong Kong. Under the partnership, KLN Pharma will manage Ego Pharmaceuticals’ entire supply chain operations across a wide range of skincare and pharmaceutical products.

KLN Pharma will oversee domestic distribution to Ego Pharmaceuticals’ retail outlets, pharmacies, drugstores and key chain channels. It will also utilise its GMP-compliant infrastructure, multi-temperature storage capabilities and proprietary inventory systems to ensure product integrity and regulatory compliance from inbound logistics, inventory management to distribution. The partnership encompasses marketing logistics support, enabling Ego Pharmaceuticals to accelerate product launches and promotional campaigns in Hong Kong’s competitive skincare and healthcare landscape.

Samuel Lau, Managing Director - Integrated Logistics of KLN, said, “We are thrilled to partner with Ego Pharmaceuticals, a company that exemplifies scientific excellence and sustainable innovation. Our 4PL model offers the agility, compliance and scalability needed to support Ego’s growth ambitions in Hong Kong.”

Ted Pitts, Global Supply Chain Manager of Ego Pharmaceuticals, said, “We are committed to delivering science-backed skincare solutions to consumers across Asia. KLN’s logistics expertise and deep understanding of pharmaceutical distribution make them an ideal partner for our Hong Kong operations.”

KLN Pharma, has grown rapidly in recent years. The company’s self-owned warehouses, advanced digital platforms and dedicated healthcare logistics team provide a strong foundation for managing complex supply chains in regulated environments. With pharmaceutical logistics projected to reach US$173 billion globally by 2030*, KLN is well-positioned to play a pivotal role in delivering integrated, consumer-centric supply chain solutions.

*Source: Pharmaceutical Logistics Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024-2030) by Prescient & Strategic Intelligence

PRESS CONTACTS
We use Cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for Cookies to be used. For more details.
Accept